Document is current
Any future updates will be listed below
-
Authors
Mansilla-Soto, Jorge https://orcid.org/0000-0003-2889-1397
Eyquem, Justin https://orcid.org/0000-0001-8262-1190
Haubner, Sascha https://orcid.org/0000-0002-5348-1456
Hamieh, Mohamad https://orcid.org/0000-0003-2146-4755
Feucht, Judith
Paillon, Noémie https://orcid.org/0000-0002-6848-3016
Zucchetti, Andrés Ernesto
Li, Zhuoning
Sjöstrand, Maria
Lindenbergh, Pieter L.
Saetersmoen, Michelle
Dobrin, Anton https://orcid.org/0000-0002-9751-0677
Maurin, Mathieu
Iyer, Archana
Garcia Angus, Andreina
Miele, Matthew M. https://orcid.org/0000-0001-7495-2133
Zhao, Zeguo
Giavridis, Theodoros
van der Stegen, Sjoukje J. C. https://orcid.org/0000-0002-3839-3124
Tamzalit, Fella
Rivière, Isabelle
Huse, Morgan https://orcid.org/0000-0001-9941-7719
Hendrickson, Ronald C.
Hivroz, Claire https://orcid.org/0000-0002-6794-2890
Sadelain, Michel https://orcid.org/0000-0002-9031-8025
- License Information
-
More Information
Article History
Received: 30 July 2020
Accepted: 8 November 2021
First Online: 13 January 2022
Competing interests
: Memorial Sloan Kettering has submitted a patent application based in part on results presented in this manuscript (WO2019157454A1, J.M.-S., J.E. and M.S. are listed among the inventors). R.C.H. reports stock ownership in Merck. M.S. reports research funding from Juno Therapeutics, Fate Therapeutics, Takeda Pharmaceuticals and Atara Biotherapeutics, unrelated to the present research. M.S., I.R. and J.E. are scientific cofounders of Mnemo Therapeutics. M.S. serves on the scientific advisory board of St. Jude Children Research Hospital. All other authors declare no competing interests.
